Brief: TAS Partners Llc Reports 2.4% Stake In Cartesian Therapeutics As Of Oct 2 Versus 11.7% As Of Sept 25 - SEC Filing
04/10/2024 23:23
Cartesian Therapeutics Inc RNAC.O :
* TAS PARTNERS LLC REPORTS 2.4% STAKE IN CARTESIAN
THERAPEUTICS AS
OF OCT 2 VERSUS 11.7% AS OF SEPT 25 - SEC FILING
Source text for Eikon: ID:n0001213900-24-085663
Further company coverage: RNAC.O
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview